Xie Jianling, Kuppermann Nathan, Florin Todd A, Tancredi Daniel J, Funk Anna L, Kim Kelly, Salvadori Marina I, Yock-Corrales Adriana, Shah Nipam P, Breslin Kristen A, Chaudhari Pradip P, Bergmann Kelly R, Ahmad Fahd A, Nebhrajani Jasmine R, Mintegi Santiago, Gangoiti Iker, Plint Amy C, Avva Usha R, Gardiner Michael A, Malley Richard, Finkelstein Yaron, Dalziel Stuart R, Bhatt Maala, Kannikeswaran Nirupama, Caperell Kerry, Campos Carmen, Sabhaney Vikram J, Chong Shu-Ling, Lunoe Maren M, Rogers Alexander J, Becker Sarah M, Borland Meredith L, Sartori Laura F, Pavlicich Viviana, Rino Pedro B, Morrison Andrea K, Neuman Mark I, Poonai Naveen, Simon Norma-Jean E, Kam April J, Kwok Maria Y, Morris Claudia R, Palumbo Laura, Ambroggio Lilliam, Navanandan Nidhya, Eckerle Michelle, Klassen Terry P, Payne Daniel C, Cherry Jonathan C, Waseem Muhammad, Dixon Andrew C, Ferre Isabel Beneyto, Freedman Stephen B
University of Calgary, Calgary, Alberta, Canada.
Davis School of Medicine, University of California, Sacramento, California, USA.
Open Forum Infect Dis. 2023 Oct 3;10(10):ofad485. doi: 10.1093/ofid/ofad485. eCollection 2023 Oct.
To assist clinicians with identifying children at risk of severe outcomes, we assessed the association between laboratory findings and severe outcomes among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected children and determined if SARS-CoV-2 test result status modified the associations.
We conducted a cross-sectional analysis of participants tested for SARS-CoV-2 infection in 41 pediatric emergency departments in 10 countries. Participants were hospitalized, had laboratory testing performed, and completed 14-day follow-up. The primary objective was to assess the associations between laboratory findings and severe outcomes. The secondary objective was to determine if the SARS-CoV-2 test result modified the associations.
We included 1817 participants; 522 (28.7%) SARS-CoV-2 test-positive and 1295 (71.3%) test-negative. Seventy-five (14.4%) test-positive and 174 (13.4%) test-negative children experienced severe outcomes. In regression analysis, we found that among SARS-CoV-2-positive children, procalcitonin ≥0.5 ng/mL (adjusted odds ratio [aOR], 9.14; 95% CI, 2.90-28.80), ferritin >500 ng/mL (aOR, 7.95; 95% CI, 1.89-33.44), D-dimer ≥1500 ng/mL (aOR, 4.57; 95% CI, 1.12-18.68), serum glucose ≥120 mg/dL (aOR, 2.01; 95% CI, 1.06-3.81), lymphocyte count <1.0 × 10/L (aOR, 3.21; 95% CI, 1.34-7.69), and platelet count <150 × 10/L (aOR, 2.82; 95% CI, 1.31-6.07) were associated with severe outcomes. Evaluation of the interaction term revealed that a positive SARS-CoV-2 result increased the associations with severe outcomes for elevated procalcitonin, C-reactive protein (CRP), D-dimer, and for reduced lymphocyte and platelet counts.
Specific laboratory parameters are associated with severe outcomes in SARS-CoV-2-infected children, and elevated serum procalcitonin, CRP, and D-dimer and low absolute lymphocyte and platelet counts were more strongly associated with severe outcomes in children testing positive compared with those testing negative.
为帮助临床医生识别有严重后果风险的儿童,我们评估了实验室检查结果与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染儿童严重后果之间的关联,并确定SARS-CoV-2检测结果状态是否改变了这种关联。
我们对10个国家41个儿科急诊科接受SARS-CoV-2感染检测的参与者进行了横断面分析。参与者均住院治疗,接受了实验室检查,并完成了14天的随访。主要目的是评估实验室检查结果与严重后果之间的关联。次要目的是确定SARS-CoV-2检测结果是否改变了这种关联。
我们纳入了1817名参与者;522名(28.7%)SARS-CoV-2检测呈阳性,1295名(71.3%)检测呈阴性。75名(14.4%)检测呈阳性和174名(13.4%)检测呈阴性的儿童出现了严重后果。在回归分析中,我们发现,在SARS-CoV-2阳性儿童中,降钙素原≥0.5 ng/mL(调整优势比[aOR],9.14;95%置信区间[CI],2.90 - 28.80)、铁蛋白>500 ng/mL(aOR,7.95;95% CI,1.89 - 33.44)、D-二聚体≥1500 ng/mL(aOR,4.57;95% CI,1.12 - 18.68)、血糖≥120 mg/dL(aOR,2.01;95% CI,1.06 - 3.81)、淋巴细胞计数<1.0×10⁹/L(aOR,3.21;95% CI,1.34 - 7.69)以及血小板计数<150×10⁹/L(aOR,2.82;95% CI,1.31 - 6.07)与严重后果相关。对交互项的评估显示,SARS-CoV-2检测结果呈阳性增加了降钙素原、C反应蛋白(CRP)、D-二聚体升高以及淋巴细胞和血小板计数降低与严重后果之间的关联。
特定的实验室参数与SARS-CoV-2感染儿童的严重后果相关,与检测呈阴性的儿童相比,血清降钙素原、CRP和D-二聚体升高以及绝对淋巴细胞和血小板计数低与检测呈阳性的儿童严重后果的关联更强。